Wyatt Share Discussion Threads

[chancer6] 12/7/2007 10:01

Trades delayed in reporting by 2 hours. My 5K buy at 14.75 pence has just come through!

[chancer6] 12/7/2007 09:54

6th highest gainer now today, further increases will put WYT on the radar.

[currypasty] 12/7/2007 09:37

A quick check for a dummy buy gave a buy price of 16.15 for 5k

[currypasty] 12/7/2007 09:34

spread is large, but they usually trade within it...

[chancer6] 12/7/2007 09:33

14.00-18.00 pence, Level 2 is 2 v 2. IMO the Interims produced a spike to 23 pence, the results out today should produce a spike to the 30 pence levels at the very least!

[currypasty] 12/7/2007 09:22

Its a slow start this morning, buy hopefully things will get going as people read the results

[chancer6] 12/7/2007 09:20

SCAP moved up on the bid, 14.00-17.00 pence.

[chancer6] 12/7/2007 08:42

Wyatt Group swings to FY pretax profit on higher turnover UPDATE

(Adds details on PES unit)
LONDON (Thomson Financial) - Wyatt Group PLC swung to a full-year pretax
profit on a 131 pct rise in turnover and said that it is confident of a strong
performance in the current year for its PES consulting unit.
The UK consultancy services group posted a pretax profit of 108,201 stg for
the year to March 31, 2007 against a loss of 717,259 stg last year. Turnover
rose to 2.97 mln stg from 1.26 mln a year ago.
The company said its biotech business experienced unforeseen delays in the
testing and production of the drug testing product, resulting in it not being
ready to begin market trials.
The group is therefore taking steps to limit further funding for ongoing
costs and it is intended that the costs will instead be met by the US
inventor/developer. In return, Wyatt Biotech will become a joint venture between
Wyatt and the US inventor, it added.
Wyatt said its PES unit has made significant progress in 2006/07 and has
continued to develop its range of products and services. PES is currently
marketing a tax product, generating significant revenues and giving it access to
several blue-chip clients.

[chancer6] 12/7/2007 08:41

Another few tick ups will get these on the radar. Buy price is still 15.55 pence.

[currypasty] 12/7/2007 08:18

Wyatt Group swings to FY pretax profit on higher turnover


LONDON (Thomson Financial) - Wyatt Group PLC swung to a full-year pretax
profit on a 131 pct rise in its turnover and said that it is confident about a
strong performance in the current year for its PES consulting unit.
The UK consultancy services group posted a pretax profit of 108,201 stg for
the year to March 31, 2007 against a loss of 717,259 stg last year. Turnover
rose to 2.97 mln stg from 1.26 mln a year ago.
The company said its biotech business has seen unforeseen delays in the
testing and production of the drug testing product, resulting in it not being
ready to begin market trials.
The group is therefore taking steps to limit further funding for ongoing
costs and it is intended that the costs will instead be met by the US
inventor/developer. In return, Wyatt Biotech will become a joint venture between
Wyatt and the US inventor, it added

[chancer6] 12/7/2007 08:12

Thanks for that CurryPasty!

[currypasty] 12/7/2007 08:11

we have been to 40p twice before, and then it was on hope of good turnover, and profit... now we have proof that all the component parts are viable, and can look forward to building on those increses in net profit, and turnover.
40p would still only be under 5 mil mcap...

[chancer6] 12/7/2007 08:06

Level 2 is 2 v 2. Can pick up some still online but at 15.65 pence.

[chancer6] 12/7/2007 08:05

What valuation i.e. share price would you put on these now CurryPasty?

[currypasty] 12/7/2007 08:04

It has a history of rising very fast on good news, but dropping off in the months after, as people get fed up. Hopefully now the Company is doing so well, there may be an increase in the PR and newsflow to keep the shareprice stable...

[chancer6] 12/7/2007 08:01

Excellent set of results! Managed to pick up 5,000 shares at 14.75 pence. Could rise v.heavily today IMHO.

[currypasty] 12/7/2007 08:01

This was on a turnover of #2,990,863 (2006: #1,296,149) which represents an increase of 131%. The profit attributable to shareholders (after amortisation, depreciation, interest, joint venture interests, minority interests and tax was #121,589 (2006: #687,280 loss).




well undervalued IMHO, at only 1.8m MCAP

turnover more than doubled, £687k loss to £121k maiden profit

what will next year be, if they carry on at this rate ?

[currypasty] 12/7/2007 07:48

WYATT GROUP PLC AND ITS SUBSIDIARY UNDERTAKINGS

PRELIMINARY RESULTS ANNOUNCEMENT FOR THE YEAR ENDED
31 March 2007



I am delighted to report on what has been a significant year in the Group's
development. It is a pleasure to be able to announce that the Group made an
operating profit before joint venture, amortisation and interest of #353,662
compared to a loss last year of #541,571. This was on a turnover of #2,990,863
(2006: #1,296,149) which represents an increase of 131%. The profit attributable
to shareholders (after amortisation, depreciation, interest, joint venture
interests, minority interests and tax was #121,589 (2006: #687,280 loss).



Operations



The Group's principal subsidiaries are Risksmart Limited, Premier Employer
Solutions Limited ('PES') and Wyatt Biotech Limited.



Risksmart provides an on-line fire risk assessment solution for small and medium
sized businesses. The long awaited Fire Safety legislation became effective on
1st October 2006. This has been the turning point that the team were awaiting
and Risksmart is now close to trading profitably on a month on month basis. This
is just reward for the management team who have worked hard to build the
foundations despite the continued set-backs that the considerable delays in
implementing the legislation have presented.



PES provides a range of employment related consultancy and support services
focused around human resources, reward and employment tax. It has made
significant progress in 2006/07 and has continued to develop its range of
products and services and to build on its impressive client base. The results
for the year ended 31 March 2007 are excellent with the company generating a
profit for the year after tax. PES is currently marketing a tax product that has
proved tremendously successful, generating significant revenues and giving it
access to a number of high profile blue chip clients. The management team are
reinvesting much of the revenues generated from this product into building and
expanding the core business activities of PES. The beginning of the current
financial year has already been encouraging and we are confident of yet another
strong performance.



Wyatt Biotech is the Group's drug testing operation. It has been a long and
frustrating year for this business. There have been unforeseen delays in the
testing and production of the drug testing product, resulting in it still not
being ready to commence market trials. I believe that if these issues can be
overcome then there is an exciting future for this business. However, in the
short term the Group is taking steps to limit further funding for ongoing costs.
It is intended that these costs will instead be met by the US inventor/developer
who will inject funds into the business to bring the product up to the point
where it can be taken to market. In return, the company will become a joint
venture between Wyatt and the US inventor. I believe that this course of action
is in the best interests of our shareholders.



Prospects



This is a fantastic turnaround for the Group and hopefully indicates to
shareholders that their continued patience and belief will be rewarded in the
future. I would like to thank everybody involved in Wyatt for their hard work
and dedication. We have now built a platform for growth and with continued hard
work we will be able to take Wyatt to the next level.



R Holt
Chairman
11 July 2007

[tonyx] 10/7/2007 20:29

Who, me or the MM's? ;-)

[swag2] 10/7/2007 20:23

cheapskate!

[tonyx] 10/7/2007 17:47

MMs having a field day...some poor fellow only got 11p for 12286.

MM's would only let me have some 14.3p so I declined. 13p & I'll be interested.

[currypasty] 10/7/2007 15:46

i bought my first shares in the placing done by their brokers at the time Rowan dartington, who has since merged with Corporate Synergy...

CS/ RD corporate arm is called Blue oar

[swag2] 10/7/2007 15:36

Who are their current brokers? It would be nice to get some decent trumpeting of the results if they are as good as the trading statement suggests.

Does this share ever go up for long? ;-)

[currypasty] 10/7/2007 12:02

25k sell at 12p

reminds me of April, someone sold 45k at 5p... yes market makers had a laugh.. 3 days later they were 22p, after the trading statement..


Results out thursday i was told


anyone want a punt, put a limit order in, mm's can afford to give some discount, after the 25k at 12